- Home
- ACAD vs HOG Comparison
ACAD vs HOG Comparison
Compare ACAD & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- HOG
- Stock Information
- Founded
- ACAD 1993
- HOG 1903
- Country
- ACAD United States
- HOG United States
- Employees
- ACAD N/A
- HOG N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- HOG Motor Vehicles
- Sector
- ACAD Health Care
- HOG Consumer Discretionary
- Exchange
- ACAD Nasdaq
- HOG Nasdaq
- Market Cap
- ACAD 3.4B
- HOG 3.4B
- IPO Year
- ACAD 2004
- HOG N/A
- Fundamental
- Price
- ACAD $19.95
- HOG $26.42
- Analyst Decision
- ACAD Buy
- HOG Buy
- Analyst Count
- ACAD 19
- HOG 7
- Target Price
- ACAD $25.33
- HOG $34.14
- AVG Volume (30 Days)
- ACAD 1.6M
- HOG 2.6M
- Earning Date
- ACAD 02-26-2025
- HOG 02-05-2025
- Dividend Yield
- ACAD N/A
- HOG 2.73%
- EPS Growth
- ACAD N/A
- HOG N/A
- EPS
- ACAD 0.78
- HOG 3.44
- Revenue
- ACAD $929,236,000.00
- HOG $5,186,802,000.00
- Revenue This Year
- ACAD $36.88
- HOG N/A
- Revenue Next Year
- ACAD $8.01
- HOG $4.56
- P/E Ratio
- ACAD $25.70
- HOG $7.68
- Revenue Growth
- ACAD 47.06
- HOG N/A
- 52 Week Low
- ACAD $14.15
- HOG $25.25
- 52 Week High
- ACAD $26.56
- HOG $44.16
- Technical
- Relative Strength Index (RSI)
- ACAD 60.25
- HOG 40.88
- Support Level
- ACAD $19.52
- HOG $25.64
- Resistance Level
- ACAD $20.29
- HOG $27.21
- Average True Range (ATR)
- ACAD 0.68
- HOG 0.98
- MACD
- ACAD 0.08
- HOG 0.16
- Stochastic Oscillator
- ACAD 72.62
- HOG 49.79
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 38% of the heavyweight domestic market in 2023.